Copyright: ©Author(s) 2026.
World J Gastrointest Endosc. Jun 16, 2026; 18(6): 117354
Published online Jun 16, 2026. doi: 10.4253/wjge.v18.i6.117354
Published online Jun 16, 2026. doi: 10.4253/wjge.v18.i6.117354
Table 1 Summarizes the relative advantages, limitations, and ideal indications for endoscopic mucosal resection, endoscopic submucosal dissection, argon plasma coagulation, and cryoballoon ablation, highlighting the therapeutic niche where cryoballoon ablation may offer benefit
| Treatment | Advantages | Limitations | Major risks | Best candidates |
| EMR[6,7] | Widely available; first-line therapy | Difficult in large or fibrotic lesions; non-lifting | Delayed bleeding (17%-20%); perforation (4%-5%) | ≤ 20-30 mm, non-fibrotic lesions[6,7] |
| Cold snare resection[9] | Non-thermal; Lower perforation risk; technically simple | Limited in fibrotic or non-lifting lesions; piecemeal in larger lesions | Delayed bleeding (low); recurrence possible | Small-to-medium |
| ESD[12,28] | En bloc resection with clear margins | Technically demanding; limited working space in duodenum | Perforation (20%-45%) delayed bleeding | Highly selected lesions in expert centers |
| APC[12,30] | Simple; useful for small residual areas | Limited depth; higher recurrence | Rare delayed bleeding; thermal spread possible | Small residual adenoma within scar tissue |
| CBA[15,26] | Favorable safety profile; uniform, depth-limited injury | Superficial ablation only; may require repeat sessions; no histology | Mild pancreatitis; uneven balloon-mucosa contact; no perforations reported in published series | Flat, fibrotic, recurrent, non-circumferential lesions |
Table 2 Clinical advantages and appropriate indications of cryoballoon ablation
| Potential advantages | Appropriate indications | Lesions unsuitable for CBA |
| Depth-limited uniform injury (reduced perforation risk) | Benign non-ampullary duodenal adenomas (Paris 0-IIa/IIb) | Bulky circumferential lesions (> 5 cm) |
| Preservation of submucosal collagen matrix | Recurrent or fibrotic (non-lifting) lesions | Suspected deep submucosal invasion |
| Non-thermal mechanism avoiding coagulative necrosis | Residual adenoma within scar tissue or near clips | Lesions requiring histologic margin assessment |
| Technically simple balloon-based delivery system | Lesions in angulated or technically challenging locations |
- Citation: Seo JY, Yoo JH. Expanding the therapeutic spectrum for duodenal adenomas: Cryoballoon ablation. World J Gastrointest Endosc 2026; 18(6): 117354
- URL: https://www.wjgnet.com/1948-5190/full/v18/i6/117354.htm
- DOI: https://dx.doi.org/10.4253/wjge.v18.i6.117354